Tuberculosis Trials Consortium Services
Award Notice Posted
- Solicitation number
- 75D30120R67869
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D30121C10167 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Cotonou BEN
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention awarded a cost reimbursable contract valued at $13,589,077 to RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE to provide tuberculosis trials consortium services through 2023. This competitive award will support CDC's tuberculosis control and elimination initiatives through clinical trials consortium activities over a three year period to assist CDC's efforts to control and eliminate tuberculosis.
Notice text
This is a competitive cost reimbursable award.
Awarded contract 75D30121C10167 to RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE for 13589077.00 on 2020-12-18.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Tuberculosis Trials Consortium Services | Award Notice | |
| Tuberculosis Trials Consortium Services | Award Notice | |
| This notice | Award Notice | |
| Tuberculosis Trials Consortium Services | Award Notice | |
| Tuberculosis Trials Consortium Services | Solicitation | |
| Tuberculosis Trials Consortium Services | Pre-Solicitation |
6 of 8 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity